81 unknown. 81 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 81 | Unknown 81 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LIROH - Liraglutide for Obesity in HIV Liraglutide - Obesity, HIV Infections | Phase 4 | Unknown | Brigham and Women's Hospital | 40 | 2024-05-02 | 2024-05-31 |
| Semaglutide 2.4mg for Low Responders After Bariatric Surgery Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY] - Obesity, Obesity, Morbid | Phase 4 | Unknown | Zuyderland Medisch Centrum | 152 | 2024-05-01 | 2024-03-01 |
| Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes Henagliflozin, Placebo - Obese, Weight Loss | Phase 4 | Unknown | The First People's Hospital of Changzhou | 300 | 2024-02-15 | 2024-01-22 |
| The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty Esomeprazole - Obesity | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 40 | 2024-02-01 | 2024-02-28 |
| The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients Semaglutide, standard of care - Type 2 Diabetes, Overweight | Phase 4 | Unknown | University Hospital Sestre Milosrdnice | 60 | 2024-02-01 | 2024-02-06 |
| Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease Liraglutide, Orlistat - Non-alcoholic Fatty Liver Disease, Obesity | Phase 4 | Unknown | Affiliated Hospital of Nantong University | 102 | 2023-11-01 | 2024-07-15 |
| Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section 5mg bupivacaine, 10mg bupivacaine - Anesthesia, Obstetric Anesthesia Problems | Phase 4 | Unknown | Hospital Civil de Guadalajara | 106 | 2023-08-01 | 2023-09-29 |
| A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities Saroglitazar - NAFLD, Obesity | Phase 4 | Unknown | Zydus Lifesciences Limited | 1500 | 2023-07-20 | 2024-02-07 |
| Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL, Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG - PCOS (Polycystic Ovary Syndrome), Semaglutide | Phase 4 | Unknown | Peking University First Hospital | 75 | 2023-05-09 | 2024-03-25 |
| Semaglutide and Vascular Regeneration Semaglutide Pen Injector - Atherosclerosis, Cardiovascular Diseases | Phase 4 | Unknown | Canadian Medical and Surgical Knowledge Translation Research Group | 100 | 2023-04-29 | 2023-07-25 |
| Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG). Pregabalin 150mg, Placebo - Obesity, Postoperative Pain | Phase 4 | Unknown | Medical University of Warsaw | 90 | 2023-04-24 | 2024-09-19 |
| Use of Mysimba in Patients With Weight Regain After Bariatric Surgery Naltrexone-Bupropion Combination - Obesity, Morbid, Bariatric Surgery Candidate | Phase 4 | Unknown | Zuyderland Medisch Centrum | 116 | 2023-03-21 | 2023-05-30 |
| Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain Biktarvy, Symtuza - HIV Infections, Obesity | Phase 4 | Unknown | East Carolina University | 30 | 2023-03-14 | 2023-11-14 |
| The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting Aprepitant, Placebo - Obesity, Nausea and Vomiting, Postoperative | Phase 4 | Unknown | Hospital General Tlahuac | 400 | 2022-12-01 | 2023-03-16 |
| Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients Remimazolam besylate - Remimazolam, Desflurane | Phase 4 | Unknown | Seoul National University Bundang Hospital | 88 | 2022-10-25 | 2023-08-14 |
| Efficacy of Oral Semaglutide in Overweight or Obesity oral semaglutide - Obesity, Weight Loss | Phase 4 | Unknown | Asian Institute of Gastroenterology, India | 116 | 2022-07-10 | 2022-07-20 |
| Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets Semaglutide Pen Injector [Ozempic], Very-low Calorie Diet - Type 2 Diabetes Mellitus in Obese | Phase 4 | Unknown | University of Nottingham | 45 | 2021-09-15 | 2022-11-04 |
| Empagliflozin and Atrial Fibrillation Treatment Empagliflozin, Placebo - Atrial Fibrillation, Heart Failure | Phase 4 | Unknown | Miulli General Hospital | 400 | 2021-09-01 | 2021-04-02 |
| The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Beinaglutide, Dulaglutide - Diabetes Mellitus, Type 2, Overweight or Obesity | Phase 4 | Unknown | Second Xiangya Hospital of Central South University | 120 | 2021-05-01 | 2023-03-17 |
| A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery Contrave 8Mg-90Mg Extended-Release Tablet, Placebo - Obesity | Phase 4 | Unknown | St. Joseph's Healthcare Hamilton | 18 | 2021-04-01 | 2023-08-03 |
Showing 20 of 81. Sign in to see all of them.
Obesity (69) · Diabetes Mellitus, Type 2 (14) · Obesity, Morbid (9) · Insulin Resistance (5) · Weight Loss (5) · Hypertension (4) · Metabolic Syndrome (4) · Polycystic Ovary Syndrome (4) · Diabetes Mellitus (3) · HIV Infections (3) · Behavior (2) · Glucose Intolerance (2) · Motor Activity (2) · Non-alcoholic Fatty Liver Disease (2)
Nutrition Disorders (81) · Nutritional and Metabolic Diseases (81) · Overnutrition (81) · Pathological Conditions, Signs and Symptoms (81) · Signs and Symptoms (81) · Body Weight (80) · Metabolic Diseases (27) · Glucose Metabolism Disorders (25) · Endocrine System Diseases (21) · Diabetes Mellitus (15) · Obesity (11) · Urogenital Diseases (9) · Genital Diseases (8) · Hyperinsulinism (8)
Liraglutide (8) · Metformin (7) · semaglutide (6) · Exercise (3) · bupropion hydrochloride, naltrexone hydrochoride drug combination (3) · moxonidine (3) · Dexmedetomidine (2) · Diet (2) · Hydroxychloroquine (2) · Naltrexone-Bupropion combination (2) · Orlistat (2) · Simvastatin (2) · Sodium Chloride (2) · empagliflozin (2) · saxagliptin (2)
Universitaire Ziekenhuizen KU Leuven (4) · Baker Heart and Diabetes Institute (2) · Guangzhou General Hospital of Guangzhou Military Command (2) · Ingrid Jazet (2) · Medical University of Warsaw (2) · Royal Perth Hospital (2) · St. Joseph's Healthcare Hamilton (2) · University of Milan (2) · University of Nottingham (2) · Zuyderland Medisch Centrum (2) · Affiliated Hospital of Nantong University (1) · Aristotle University Of Thessaloniki (1) · Asian Institute of Gastroenterology, India (1) · Baker Heart Research Institute (1) · Beijing Chao Yang Hospital (1)
China (9) · Italy (8) · Australia (5) · Netherlands (5) · Poland (5) · Mexico (4) · United States (4) · Canada (3) · Denmark (3) · France (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Greece (2) · India (2)
Jan Tack (3) · Ingrid Jazet, MD (2) · Achille Tolino, MD (1) · Alexandros Kokkinos, MD, PhD (1) · Anand V Kulkarni, MD DM (1) · Anna Casu, MD (1) · Anudeep Katrevula, MD DM (1) · Aristithes G Doumouras, MD (1) · Arnaud De Roover, MD (1) · Ashley M Parrott, PharmD (1) · Asim Shabbir, MBBS (1) · Bertha Torres-Alvarez, MD (1) · Bimin Shi, PHD (1) · Bob Ryder, MD FRCP (1) · Chuwa Tei, MD, PhD (1)
PMID 15321413, PMID 16112958, PMID 16443140, PMID 16774830, PMID 18173431, PMID 19439456, PMID 19447599, PMID 19515542, PMID 19656312, PMID 19672175, PMID 20011857, PMID 20035530, PMID 20455872, PMID 21307769, PMID 21334503, PMID 21334504, PMID 21893621, PMID 21932999, PMID 22108086, PMID 22326199, PMID 22451451, PMID 22813360, PMID 23092743, PMID 23135692, PMID 23262963, PMID 23460761, PMID 23765186, PMID 23969793, PMID 23997449, PMID 24030946, PMID 24034832, PMID 24153001, PMID 24362411, PMID 24946047, PMID 25146109, PMID 25201313, PMID 25393047, PMID 25493403, PMID 25650964, PMID 25821536, PMID 25885106, PMID 25936783, PMID 26588260, PMID 26658988, PMID 26692415, PMID 26694495, PMID 26943657, PMID 27574464, PMID 27629425, PMID 27633186
2014 (1), 2015 (1), K23DK125162 (1)